(Fighting New Coronary Pneumonia) Cuba's first new coronavirus vaccine in Latin America has an effective rate of over 92%
China News Service, Beijing, June 23.
According to Agence France-Presse, the Cuban Biomedical Group issued an announcement stating that the new crown vaccine "Avdara" developed by the Cuban Genetics and Bioengineering Center has an effective rate of 92.
In addition, the Finlay Institute of Vaccines in Cuba announced on the 19th that its three-dose new crown vaccine "Sovereign 02" can reach an effective rate of 62% after two doses.
Cuban President Diaz-Canel praised on social media: “Even after the epidemic, the scientists at the Finlay Institute for Vaccine Research and the Center for Genetics and Bioengineering have overcome numerous obstacles and developed two exceptional models for us.
According to Turkey's Anadolu News Agency, Venezuela, Argentina, Mexico, Iran and other countries have expressed interest in purchasing Cuban self-developed vaccines
Since 2017, the U.
According to Cuban official statistics, nearly 1 million of the country's approximately 11.
Focus on the new crown pneumonia epidemic
This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only.
This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of
the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed
description of the concern or complaint, to
service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content
will be removed immediately.